Endometrial cancer screening

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer screening
CDC on Endometrial cancer screening
Endometrial cancer screening in the news
Blogs on Endometrial cancer screening
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]Roukoz A. Karam, M.D.[3]

Overview

There is insufficient evidence to recommend routine screening for endometrial cancer.^[1]

There is insufficient evidence to recommend routine screening for endometrial cancer.^[1]

Women with Lynch syndrome have a risk of developing endometrial cancer up to 50% higher than the general population.

Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member).^[2]